Literature DB >> 10632479

Growth factor-induced expression of macrophage migration inhibitory factor in osteoblasts: relevance to the plasminogen activator system.

S Onodera1, K Suzuki, K Kaneda, M Fujinaga, J Nishihira.   

Abstract

Macrophage migration inhibitory factor (MIF) is a cytokine that mediates inflammatory processes in a variety of tissues. In this study, we examined the expression of MIF mRNA in the mouse osteoblastic cell line MC3T3-E1, whose proliferation is promoted by various growth factors. In the subconfluent state, transforming growth factor-beta, basic fibroblast growth factor, insulin-like growth factor-II, and fetal calf serum markedly upregulated MIF mRNA expression. The upregulation of MIF mRNA was less extensive when the cells were stimulated by the same growth factors in the overconfluent state. We also investigated the expression of MIF mRNA through a whole cell cycle from G0 phase when the osteoblastic cells were synchronized by serum starvation. The MIF mRNA expression, which gradually increased from the G0 and reached its maximum at the S phase, was nonperiodic. Moreover, human recombinant MIF upregulated the expression of urokinase plasminogen activator inhibitor-1 (PAI-1) precursor mRNA in human osteoblastic Saos-2 cells. Plasminogen activator (PA) is known to play an important role in bone metabolism, for example, in activation of procollagenase or growth factors indirectly via the formation of plasmin, and in mitogenic activity for osteoblastic cells. Our results suggest that MIF modulates the proliferation of osteoblasts and, moreover, bone tissue remodeling through the PA and plasmin system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10632479     DOI: 10.1055/s-2007-994966

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  7 in total

Review 1.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

2.  Characterization of Neospora caninum macrophage migration inhibitory factor.

Authors:  Guanggang Qu; Raymond Fetterer; Mark Jenkins; Lin Leng; Zhiqiang Shen; Charles Murphy; Wenyu Han; Richard Bucala; Wenbin Tuo
Journal:  Exp Parasitol       Date:  2013-07-11       Impact factor: 2.011

Review 3.  Osteoimmunology: cytokines and the skeletal system.

Authors:  Seoung-Hoon Lee; Tae-Soo Kim; Yongwon Choi; Joseph Lorenzo
Journal:  BMB Rep       Date:  2008-07-31       Impact factor: 4.778

4.  High macrophage migration inhibitory factor levels in disseminated intravascular coagulation patients with systemic inflammation.

Authors:  Satoshi Gando; Atsushi Sawamura; Mineji Hayakawa; Hirokatsu Hoshino; Nobuhiko Kubota; Jun Nishihira
Journal:  Inflammation       Date:  2007-05-30       Impact factor: 4.092

5.  Macrophage migration inhibitory factor regulates joint capsule fibrosis by promoting TGF-β1 production in fibroblasts.

Authors:  Yuxin Zhang; Zhonglong Liu; Kexin Wang; Shenji Lu; Shuai Fan; Lili Xu; Bin Cai
Journal:  Int J Biol Sci       Date:  2021-04-29       Impact factor: 6.580

6.  Modulation of expression and cellular distribution of p21 by macrophage migration inhibitory factor.

Authors:  Elliott Taranto; Jin R Xue; Eric F Morand; Michelle Leech
Journal:  J Inflamm (Lond)       Date:  2009-08-24       Impact factor: 4.981

Review 7.  Diacerein as a disease-modulating agent in osteoarthritis.

Authors:  G Falgarone; M Dougados
Journal:  Curr Rheumatol Rep       Date:  2001-12       Impact factor: 4.686

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.